Impact of three surgical approaches on the therapeutic efficacy of intraventricular craniopharyngiomas: a single-center retrospective analysis
- PMID: 37697178
- DOI: 10.1007/s10143-023-02146-6
Impact of three surgical approaches on the therapeutic efficacy of intraventricular craniopharyngiomas: a single-center retrospective analysis
Abstract
This study aimed to investigate the therapeutic efficacy of three different surgical approaches for the treatment of intraventricular craniopharyngiomas (IVCs). The three surgical approaches investigated in this study were the endoscopic endonasal approach (EEA), pterional trans-lamina terminalis approach (PTA), and interhemispheric trans-lamina terminalis approach (ITA). Patient demographics, preoperative symptoms, endocrine and hypothalamic status, tumor characteristics, and surgical outcomes were analyzed and compared among the different surgical groups. A total of 31 patients with IVCs were included in the analysis, with 12 patients in the EEA group, 8 patients in the ITA group, and 11 patients in the PTA group. The mean follow-up time was 39 ± 23 months. Statistical analysis of the data revealed significant differences in the gross total resection (GTR) rate among the three surgical groups (P = 0.033). The GTR rate for the EEA group was 100%, that for the ITA group was 88%, and that for the PTA group was 64%, which was the lowest rate observed. After surgery, only 8.3% of the patients in the EEA group did not experience new postoperative hypopituitarism, while the percentages in the ITA and PTA groups were 75% and 73%, respectively (P = 0.012). Finally, we found that postoperative hypopituitarism may be related to the transection of the pituitary stalk during the operation (P = 0.020). Based on the results of this study, we recommend using the EEA and the ITA instead of the PTA for the surgical resection of IVCs. Furthermore, the appropriate surgical approach should be selected based on the tumor's growth pattern.
Keywords: Approach; Craniopharyngioma; Endoscopic endonasal; Intraventricular; Trans-lamina terminalis.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Comment in
-
Preoperative MRI diagnosis of papillary craniopharyngiomas: the revealing clues.Neurosurg Rev. 2023 Dec 8;47(1):8. doi: 10.1007/s10143-023-02232-9. Neurosurg Rev. 2023. PMID: 38066315 No abstract available.
Similar articles
-
Feasibility of endoscopic endonasal resection of intrinsic third ventricular craniopharyngioma in adults.Neurosurg Rev. 2022 Aug;45(4):1-13. doi: 10.1007/s10143-022-01807-2. Epub 2022 May 22. Neurosurg Rev. 2022. PMID: 35597836 Review.
-
Endoscopic Endonasal Approach for Craniopharyngiomas with Intraventricular Extension: Case Series, Long-Term Outcomes, and Review.World Neurosurg. 2020 Dec;144:e447-e459. doi: 10.1016/j.wneu.2020.08.184. Epub 2020 Sep 2. World Neurosurg. 2020. PMID: 32890848 Review.
-
Is the chiasm-pituitary corridor size important for achieving gross-total resection during endonasal endoscopic resection of craniopharyngiomas?J Neurosurg. 2018 Sep;129(3):642-647. doi: 10.3171/2017.6.JNS163188. Epub 2017 Nov 24. J Neurosurg. 2018. PMID: 29171802
-
Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor.J Neurosurg. 2018 Sep;129(3):611-619. doi: 10.3171/2017.4.JNS162143. Epub 2017 Sep 29. J Neurosurg. 2018. PMID: 28960155
-
The role of endoscopic endonasal salvage surgery in recurrent or residual craniopharyngioma after a transcranial approach: a systematic review.Acta Neurochir (Wien). 2024 Mar 2;166(1):120. doi: 10.1007/s00701-024-05980-9. Acta Neurochir (Wien). 2024. PMID: 38430312
Cited by
-
Comparative assessment of endoscopic and microsurgery resection for intracranial ventricular tumors: a meta-analysis of 3059 patients.Acta Neurol Belg. 2025 Jun 28. doi: 10.1007/s13760-025-02835-7. Online ahead of print. Acta Neurol Belg. 2025. PMID: 40580278 Review.
-
Preoperative MRI diagnosis of papillary craniopharyngiomas: the revealing clues.Neurosurg Rev. 2023 Dec 8;47(1):8. doi: 10.1007/s10143-023-02232-9. Neurosurg Rev. 2023. PMID: 38066315 No abstract available.
-
Identification of factors related to functional prognoses in craniopharyngiomas.J Neurooncol. 2025 Apr;172(2):471-479. doi: 10.1007/s11060-024-04925-7. Epub 2025 Jan 22. J Neurooncol. 2025. PMID: 39841323 Free PMC article.
-
FAP as a prognostic biomarker and radiomics-based predictor of angiogenesis-associated recurrence in Adamantinomatous craniopharyngioma.Pituitary. 2025 Jul 1;28(4):80. doi: 10.1007/s11102-025-01552-x. Pituitary. 2025. PMID: 40591015
References
-
- Lobos EI, Freed CG, Ashe SM (1953) An intrinsic tumor of the third ventricle. J Neuropathol Exp Neurol 12:232–243. https://doi.org/10.1097/00005072-195307000-00003 - DOI - PubMed
-
- Yasargil MG et al (1990) Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg 73(1):3–11. https://doi.org/10.3171/jns.1990.73.1.0003 - DOI - PubMed
-
- Elliott RE et al (2010) Efficacy and safety of radical resection of primary and recurrent craniopharyngiomas in 86 children. J Neurosurg Pediatr 5:30–48. https://doi.org/10.3171/2009.7.PEDS09215 - DOI - PubMed
-
- Mortini P et al (2011) Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg 114:1350–1359. https://doi.org/10.3171/2010.11.JNS10670 - DOI - PubMed
-
- Cao L et al (2022) Feasibility of endoscopic endonasal resection of intrinsic third ventricular craniopharyngioma in adults. Neurosurg Rev 45:1–13. https://doi.org/10.1007/s10143-022-01807-2 - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical